Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.
Furmark T, Appel L, Michelgård A, Wahlstedt K, Ahs F, Zancan S, Jacobsson E, Flyckt K, Grohp M, Bergström M, Pich EM, Nilsson LG, Bani M, Långström B, Fredrikson M.
Furmark T, et al. Among authors: flyckt k.
Biol Psychiatry. 2005 Jul 15;58(2):132-42. doi: 10.1016/j.biopsych.2005.03.029.
Biol Psychiatry. 2005.
PMID: 16038684
Clinical Trial.